OPK Opko Health, Inc. - Common Stock
$1.39
价格 · 八月 19, 2026
截至...的财报数据 七月 27, 2026
52周区间
$1–$2
55% of range
分析师评级
BUY
10 analysts
目标价
$4
+215% upside
P/E (TTM)
-4.2
ROE
-17.6%
净利润率
-37.2%
OPK 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.39
市值
—
P/E (TTM)
-4.2
每股收益 (TTM)
$-0.30
营收 (TTM)
$607M
股息收益率
—
ROE
-17.6%
负债/权益
0.3
52周区间
$1 – $2
OPK 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$607M
2016-12-31
→
2025-12-31
EPS
$-0.30
2016-12-31
→
2025-12-31
自由现金流
$-191M
2016-12-31
→
2025-12-31
利润率
-37.2%
2025-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
OPK
同行中位数
P/E (TTM)
-4.2
43.5
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
OPK
同行中位数
Gross Margin (毛利率)
33.9%
27.6%
Operating Margin (营业利润率)
-19.4%
—
Net Profit Margin (净利润率)
-37.2%
-0.95%
ROA
-10.9%
-0.27%
ROE
-17.6%
-0.87%
ROIC
-6.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
OPK
同行中位数
Debt / Equity (负债/股东权益比率)
0.3
—
Current Ratio (流动比率)
4.0
3.4
Quick Ratio (速动比率)
3.1
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
OPK
同行中位数
Revenue YoY (营收同比增长)
-14.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-15.4%
—
Revenue CAGR 5Y (营收5年复合年增长率)
-15.8%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
OPK
同行中位数
OPK 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
10 位分析师
- 强烈买入 2 20.0%
- 买入 5 50.0%
- 持有 3 30.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
4 位分析师 · 2026-08-15
中位数
$3.00
平均值
$4.38
← 低于所有目标
$1.39
最低
$3.00
最高
$8.50
中位数目标
$3.00
+115.8%
平均目标
$4.38
+214.7%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.01 | $-0.08 | 0.07% |
| 2026年3月31日 | $-0.07 | $-0.07 | 0.00% |
| 2025年12月31日 | $-0.04 | $-0.07 | 0.03% |
| 2025年9月30日 | $0.03 | $-0.05 | 0.08% |
| 2025年6月30日 | $-0.19 | $-0.11 | -0.08% |
| 2025年3月31日 | $-0.10 | $-0.07 | -0.03% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OPK | — | -4.2 | -14.9% | -37.2% | -17.6% | 33.9% |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | — |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| LMRI | — | — | — | — | — | — |
| CSTL | $1.15B | -46.9 | 3.7% | -7.0% | -5.2% | — |
| TALK | — | — | — | — | — | — |
| GMRS | — | — | — | — | — | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $713M | $863M | $1.00B | $1.77B | $1.44B | $902M | $990M | $966M | $1.12B | $492M | $91M | |
| Cost of Revenue | $401M | $495M | $545M | $716M | · | · | · | · | $61M | $47M | $42M | $9M | |
| Gross Profit | $206M | $219M | $318M | $288M | · | · | · | · | · | · | · | · | |
| R&D Expense | $124M | $105M | $90M | $74M | $77M | $75M | $118M | $126M | $126M | $114M | $99M | $84M | |
| SG&A Expense | $223M | $304M | $301M | $373M | $469M | $356M | $343M | $358M | $415M | $407M | $197M | $58M | |
| Operating Expenses | · | · | $1.02B | $1.23B | $1.76B | $1.38B | $1.18B | $1.16B | $1.24B | $1.21B | $590M | $237M | |
| Operating Income | $-117M | $-152M | $-157M | $-226M | $19M | $58M | $-274M | $-171M | $-276M | $-97M | $-98M | $-146M | |
| Interest Expense | $0 | · | $14M | $12M | $19M | · | · | · | · | · | · | · | |
| Interest Income | $15M | $8M | $4M | $2M | $28.0K | · | · | · | · | · | · | · | |
| Other Non-op | $-30M | $207M | $-17M | $-156M | $-15M | $13M | $-11M | $2M | $10M | $4M | $8M | $-3M | |
| Pretax Income | $-241M | $-10M | $-184M | $-392M | $-14M | $49M | $-305M | $-177M | $-272M | $-97M | $-138M | $-171M | |
| Income Tax | $-16M | $43M | $4M | $-63M | $15M | $18M | $7M | $-39M | $19M | $-56M | $-114M | $24.0K | |
| Net Income | $-226M | $-53M | $-189M | $-328M | $-30M | $31M | $-315M | $-153M | $-305M | $-48M | $-30M | $-172M | |
| EPS (Basic) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 | $0.05 | $-0.53 | $-0.27 | $-0.55 | $-0.09 | · | · | |
| EPS (Diluted) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 | $0.05 | $-0.53 | $-0.27 | $-0.55 | $-0.10 | · | · | |
| Shares (Basic) | 751,132,891 | 694,019,535 | 751,765,915 | 719,060,942 | 648,077,716 | 640,655,290 | 595,454,394 | 563,143,663 | 559,160,565 | 550,846,553 | · | · | |
| Shares (Diluted) | 751,132,891 | 694,019,535 | 751,765,915 | 719,060,942 | 648,077,716 | 640,655,290 | 595,454,394 | 563,143,663 | 559,160,565 | 555,605,448 | · | · | |
| EBITDA | $-26M | · | $-52M | $-118M | · | $143M | $-180M | $-74M | $-178M | $23M | · | · |
资产负债表 30
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $364M | $427M | $96M | $153M | $135M | $72M | $85M | $96M | $91M | $169M | $194M | $97M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Receivables | $90M | $118M | $123M | $127M | $260M | $286M | $135M | $144M | $166M | $220M | $194M | $20M | |
| Inventory | $66M | $57M | $66M | $74M | $87M | $132M | $53M | $42M | $49M | $47M | $40M | $17M | |
| Prepaid Expense | $57M | $55M | $25M | $40M | $27M | $32M | $51M | $35M | $43M | $47M | $27M | $9M | |
| Other Current Assets | $8M | $11M | $8M | $6M | $6M | $5M | $16M | $4M | $9M | $8M | $903.0K | $4M | |
| Current Assets | $582M | $662M | $309M | $395M | $823M | $523M | $324M | $318M | $349M | $484M | $454M | $143M | |
| PP&E (Net) | $74M | $70M | $75M | $83M | · | $141M | $127M | $145M | $147M | $123M | $132M | $16M | |
| Accum. Depreciation | $126M | $139M | $157M | $142M | · | · | · | $112M | $86M | $57M | $27M | $11M | |
| Goodwill | $484M | $529M | $598M | $596M | $521M | $681M | $672M | $700M | $717M | $705M | $743M | $224M | |
| Intangibles | $516M | $617M | $740M | $824M | $322M | $475M | $529M | $614M | $684M | $764M | $638M | $63M | |
| Other Non-current Assets | $19M | $19M | $9M | $9M | $10M | $10M | $7M | $7M | $6M | $6M | $5M | $6M | |
| Total Assets | $1.93B | $2.20B | $2.01B | $2.17B | $2.40B | $2.47B | $2.31B | $2.45B | $2.59B | $2.77B | $2.80B | $1.27B | |
| Accounts Payable | $41M | $47M | $70M | $67M | $82M | $101M | $63M | $47M | $74M | $53M | $73M | $9M | |
| Accrued Liabilities | $84M | $118M | $90M | $98M | $193M | $241M | $165M | $204M | $226M | $198M | $168M | $61M | |
| Current Liabilities | $147M | $193M | $200M | $213M | $330M | $375M | $249M | $288M | $312M | $263M | $252M | $83M | |
| Capital Leases | $37M | $49M | $54M | $28M | $33M | $30M | $28M | $6M | $8M | $7M | $9M | $0 | |
| Deferred Tax | $126M | $141M | $127M | $126M | $148M | $137M | $119M | $115M | $149M | $165M | $226M | $167M | |
| Other Non-current Liabilities | $23M | $33M | $27M | $27M | $15M | $37M | $88M | $199M | $256M | $202M | $292M | $50M | |
| Total Liabilities | $664M | $835M | $622M | $606M | $715M | $802M | $695M | $660M | $746M | $675M | $819M | $432M | |
| Long-term Debt | $344M | $437M | $50.6K | $256M | $205M | $251M | $270M | $11M | $13M | $13M | $14M | $16M | |
| Total Debt | $346M | · | $10M | · | · | · | $4M | $11M | $13M | $13M | · | · | |
| Common Stock | $8M | $7M | $8M | $8M | $7M | $7M | $7M | $6M | $6M | $6M | $5M | $4M | |
| Paid-in Capital | $3.57B | $3.48B | $3.43B | $3.42B | $3.22B | $3.15B | $3.14B | $3.00B | $2.89B | $2.85B | $2.71B | $1.53B | |
| Retained Earnings | $-2.29B | $-2.07B | $-2.01B | $-1.82B | $-1.51B | $-1.48B | $-1.51B | $-1.20B | $-1.05B | $-730M | $-705M | $-675M | |
| Treasury Stock | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | |
| AOCI | $-21M | $-56M | $-38M | $-43M | $-30M | $-4M | $-22M | $-20M | $-528.0K | $-27M | $-23M | $-12M | |
| Stockholders' Equity | $1.27B | $1.37B | $1.39B | $1.56B | $1.69B | $1.67B | $1.61B | $1.79B | $1.84B | $2.05B | $1.96B | $836M | |
| Liabilities + Equity | $1.93B | $2.20B | $2.01B | $2.17B | $2.40B | $2.47B | $2.31B | $2.45B | $2.59B | $2.77B | $2.80B | $1.27B | |
| Shares Outstanding | · | 701,350,447 | 781,936,885 | 781,306,164 | 690,082,283 | 670,585,576 | 670,378,701 | · | · | · | · | · |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $92M | $98M | $105M | $109M | $79M | $85M | $94M | $97M | $102M | $97M | $42M | $15M | |
| Stock-based Comp | $11M | $11M | $11M | $19M | $14M | $9M | $13M | $22M | $28M | $43M | $26M | $15M | |
| Deferred Tax | $-15M | $15M | $146.0K | $-74M | $10M | $16M | $4M | $-35M | $16M | $-61M | $-124M | $-1M | |
| Amort. of Intangibles | $78M | $83M | $86M | $88M | $50M | $56M | $65M | $68M | $71M | $64M | $28M | $11M | |
| Other Non-cash | $-40M | · | $44M | $180M | · | $-101M | $31M | $-40M | $70M | $-21M | · | · | |
| Operating Cash Flow | $-179M | $-183M | $-28M | $-95M | $38M | $39M | $-173M | $-109M | $-92M | $32M | $164M | $-90M | |
| CapEx | $12M | $25M | $16M | $25M | $32M | $34M | $13M | $28M | $47M | $19M | $11M | $5M | |
| Investing Cash Flow | $230M | $352M | $-18M | $91M | $36M | $-18M | $-13M | $-26M | $-47M | $-21M | $-99M | $-6M | |
| Stock Issued | · | · | · | · | $0 | $0 | $76M | $92M | $0 | $0 | · | · | |
| Stock Repurchased | $47M | $90M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-47M | · | · | · | · | $0 | $76M | $92M | · | · | · | · | |
| Financing Cash Flow | $-118M | $184M | $-11M | $23M | $-10M | $-35M | $175M | $141M | $61M | $-35M | $33M | $7M | |
| Net Change in Cash | $-63M | $350M | $-57M | $18M | $62M | $-13M | $-11M | $5M | $-77M | $-25M | $97M | $-89M | |
| Taxes Paid | $24M | $10M | $4M | $8M | $6M | $-903.0K | $3M | $-1M | $5M | $-27M | $5M | $954.0K | |
| Free Cash Flow | $-191M | · | $-44M | $-120M | · | $6M | $-185M | $-137M | $-139M | $13M | · | · | |
| Levered FCF | $-191M | · | $-58M | · | · | · | · | · | · | · | · | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -19.4% | · | -18.2% | -22.5% | · | 4.0% | -30.4% | -17.3% | -26.2% | -6.0% | · | · | |
| Net Margin | -37.2% | · | -21.9% | -32.7% | · | 2.1% | -34.9% | -15.4% | -28.9% | -2.1% | · | · | |
| Pretax Margin | -39.8% | · | -21.3% | -39.0% | · | 3.4% | -33.8% | -17.9% | -25.8% | -6.0% | · | · | |
| EBITDA Margin | -4.2% | · | -6.0% | -11.7% | · | 10.0% | -20.0% | -7.5% | -16.7% | 1.9% | · | · | |
| ROA | -10.9% | · | -9.0% | -14.4% | · | 1.3% | -13.2% | -6.1% | -11.5% | -0.90% | · | · | |
| ROE | -17.6% | · | -13.3% | -20.6% | · | 1.9% | -19.3% | -8.6% | -15.7% | -1.2% | · | · | |
| ROIC | -6.8% | · | -11.5% | -12.1% | · | 2.2% | -17.3% | -7.4% | -15.8% | -0.83% | · | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | · | 1.5 | 1.8 | · | 1.4 | 1.3 | 1.1 | 1.1 | 1.8 | · | · | |
| Quick Ratio | 3.1 | · | 1.1 | 1.3 | · | 1.0 | 0.9 | 0.8 | 0.9 | 1.5 | · | · | |
| Debt / Equity | 0.3 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | 0.0 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -11.6 | · | · | · | · | · | · | · | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | 0.4 | 0.4 | · | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | · | · | |
| Inventory Turnover | 6.5 | · | · | · | · | · | · | · | 1.3 | 13.0 | · | · | |
| Receivables Turnover | 5.8 | · | 6.9 | 5.2 | · | 6.8 | 6.5 | 6.4 | 5.5 | 5.9 | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.9% | -17.4% | -14.0% | -43.4% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -15.4% | -26.2% | -15.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -15.8% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $607M | $713M | $863M | $1.00B | $1.77B | $1.44B | $902M | $990M | $966M | $1.12B | $492M | $91M | |
| Net Income TTM | $-226M | $-53M | $-189M | $-328M | $-30M | $31M | $-315M | $-153M | $-305M | $-48M | $-30M | $-172M | |
| Market Cap | · | · | $1.18B | $977M | · | · | · | · | · | · | · | · | |
| Enterprise Value | · | · | $1.09B | · | · | · | · | · | · | · | · | · | |
| P/E | -4.2 | -18.4 | -6.0 | -2.7 | -96.2 | 79.0 | -2.8 | -11.1 | -8.9 | -93.0 | -59.1 | -23.8 | |
| P/S | · | · | 1.4 | 1.0 | · | · | · | · | · | · | · | · | |
| P/B | · | · | 0.8 | 0.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | · | 4.7 | 23.3 | 6.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -41.9 | -10.3 | · | · | · | · | · | · | · | · | |
| P / FCF | · | · | -26.5 | -8.2 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | · | -21.2 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -24.6 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 1.3 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -23.8% | -5.4% | -16.6% | -36.8% | -1.0% | 1.3% | -36.0% | -9.0% | -11.2% | -1.1% | -1.7% | -4.2% |
损益表 18
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $164M | $124M | $148M | $152M | $157M | $150M | $184M | $174M | $182M | $174M | $182M | $179M | $265M | $238M | $185M | $180M | |
| Cost of Revenue | $84M | $78M | $84M | $102M | $107M | $107M | $99M | $134M | $131M | $132M | · | · | · | · | · | · | |
| Gross Profit | $80M | $46M | $64M | $50M | $49M | $43M | $85M | $40M | $52M | $42M | · | · | · | · | · | · | |
| R&D Expense | $33M | $29M | $33M | $30M | $30M | $31M | $30M | $29M | $24M | $22M | $19M | $19M | $18M | $33M | $20M | $19M | |
| SG&A Expense | $53M | $49M | $51M | $54M | $60M | $59M | $67M | $98M | $69M | $70M | $73M | $72M | $80M | $76M | $74M | $80M | |
| Operating Expenses | $171M | $175M | $187M | $104M | $217M | $217M | $217M | $159M | $244M | $245M | $251M | $243M | $258M | $268M | $241M | $268M | |
| Operating Income | $-7M | $-51M | $-38M | $48M | $-60M | $-67M | $-33M | $-67M | $-62M | $-71M | $-69M | $-64M | $7M | $-31M | $-55M | $-88M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $3M | $3M | $4M | $3M | $3M | $5M | $4M | $3M | $391.0K | $813.0K | $906.0K | $970.0K | $1M | $1M | $1M | $667.0K | |
| Other Non-op | $2M | $-2M | $-960.0K | $2M | $-36M | $5M | $78M | $49M | $59M | $21M | $-949.0K | $-12M | $-21M | $17M | $-45M | $-37M | |
| Pretax Income | $-13M | $-61M | $-47M | $41M | $-163M | $-73M | $35M | $48M | $-11M | $-83M | $-72M | $-78M | $-16M | $-17M | $-102M | $-126M | |
| Income Tax | $-5M | $-6M | $-16M | $20M | $-14M | $-6M | $21M | $24M | $-280.0K | $-1M | $-6M | $6M | $3M | $1M | $-17M | $-40M | |
| Net Income | $-8M | $-55M | $-31M | $22M | $-148M | $-68M | $14M | $25M | $-10M | $-82M | $-66M | $-84M | $-20M | $-18M | $-85M | $-86M | |
| EPS (Basic) | $-0.01 | $-0.07 | $-0.04 | $0.03 | $-0.19 | $-0.10 | $0.02 | $0.04 | $-0.01 | $-0.12 | $-0.09 | $-0.11 | $-0.03 | $-0.02 | $-0.13 | $-0.11 | |
| EPS (Diluted) | $-0.01 | $-0.07 | $-0.04 | $0.03 | $-0.19 | $-0.10 | $0.01 | $0.03 | $-0.01 | $-0.12 | $-0.09 | $-0.11 | · | $-0.02 | $-0.11 | $-0.11 | |
| Shares (Basic) | 755,267,276 | 758,876,415 | -1,485,606,338 | 777,154,808 | 788,006,992 | 671,577,429 | -1,404,696,712 | 694,622,466 | 697,211,592 | 706,882,189 | -1,502,992,732 | 751,525,007 | 751,727,383 | 751,506,257 | -1,404,186,408 | 750,396,263 | |
| Shares (Diluted) | 755,267,276 | 758,876,415 | 4,996,756 | 779,919,259 | 788,006,992 | 671,577,429 | -5,656,409 | 998,363,636 | 697,211,592 | · | 49,223 | 751,525,007 | · | 751,506,257 | · | 750,396,263 | |
| EBITDA | $15M | $-29M | · | $71M | $-37M | $-44M | · | $38M | $-38M | $-46M | · | $-38M | $33M | $-4M | · | $-60M |
资产负债表 29
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $332M | $364M | $412M | $267M | $429M | $427M | $400M | $41M | $76M | · | $139M | $108M | $111M | · | $181M | |
| Receivables | $82M | $80M | $90M | $95M | $99M | $96M | $118M | $107M | $105M | $111M | · | $117M | $211M | $121M | · | $123M | |
| Inventory | $62M | $64M | $66M | $65M | $66M | $64M | $57M | $59M | $60M | $59M | · | $69M | $74M | $75M | · | $71M | |
| Prepaid Expense | $56M | $49M | $57M | $52M | $59M | $54M | $55M | $57M | $32M | $25M | · | $32M | $41M | $99M | · | $39M | |
| Other Current Assets | $10M | $10M | $8M | $8M | $8M | $11M | $11M | $9M | $7M | $7M | · | $7M | $7M | $6M | · | $6M | |
| Current Assets | $500M | $535M | $582M | $627M | $583M | $738M | $662M | $630M | $358M | $391M | · | $357M | $434M | $406M | · | $414M | |
| PP&E (Net) | $71M | $73M | $74M | $75M | $75M | $71M | $70M | · | $67M | $64M | · | $78M | $79M | · | · | · | |
| Accum. Depreciation | · | · | $126M | · | · | · | $139M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $482M | $482M | $484M | $484M | $484M | $477M | $529M | $536M | $530M | $531M | · | $594M | $597M | $597M | · | $573M | |
| Intangibles | $478M | $496M | $516M | $535M | $556M | $569M | $617M | $641M | $659M | $680M | · | $758M | $782M | $804M | · | $835M | |
| Other Non-current Assets | $19M | $19M | $19M | $20M | $20M | $19M | $19M | $19M | $8M | $9M | · | $9M | $9M | $8M | · | $10M | |
| Total Assets | $1.83B | $1.86B | $1.93B | $2.00B | $1.97B | $2.13B | $2.20B | $2.26B | $1.98B | $1.97B | · | $2.06B | $2.16B | $2.17B | · | $2.22B | |
| Accounts Payable | $50M | $44M | $41M | $51M | $57M | $59M | $47M | $63M | $82M | $71M | · | $67M | $88M | $81M | · | $50M | |
| Accrued Liabilities | $78M | $83M | $84M | $96M | $91M | $113M | $118M | $123M | $95M | $89M | · | $92M | $99M | $106M | · | $112M | |
| Current Liabilities | $149M | $148M | $147M | $169M | $171M | $296M | $193M | $212M | $220M | $204M | · | $201M | $226M | $222M | · | $267M | |
| Capital Leases | $34M | $36M | $37M | $36M | $37M | $38M | $49M | $52M | $50M | $51M | · | $35M | $25M | $26M | · | $29M | |
| Deferred Tax | $108M | $115M | $126M | $130M | $113M | $129M | $141M | $128M | $119M | $122M | · | $138M | $133M | $130M | · | $135M | |
| Other Non-current Liabilities | $17M | $20M | $23M | $25M | $28M | $30M | $33M | $37M | $20M | $21M | · | $26M | $27M | $28M | · | $23M | |
| Total Liabilities | $645M | $652M | $664M | $690M | $676M | $817M | $835M | $853M | $585M | $721M | · | $612M | $624M | $618M | · | $596M | |
| Long-term Debt | $349M | $346M | $344M | $344M | $343M | $439M | $437M | $441M | $202M | $350M | $50.6K | $251M | $250M | $245M | · | $245M | |
| Total Debt | $3M | $4M | · | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $10M | $11M | · | · | · | |
| Common Stock | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | · | $8M | $8M | $8M | · | $8M | |
| Paid-in Capital | $3.56B | $3.57B | $3.57B | $3.58B | $3.60B | $3.48B | $3.48B | $3.52B | $3.54B | $3.39B | · | $3.43B | $3.43B | $3.42B | · | $3.42B | |
| Retained Earnings | $-2.35B | $-2.35B | $-2.29B | $-2.26B | $-2.28B | $-2.13B | $-2.07B | $-2.08B | $-2.10B | $-2.09B | · | $-1.95B | $-1.86B | $-1.84B | · | $-1.74B | |
| Treasury Stock | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| AOCI | $-28M | $-27M | $-21M | $-25M | $-25M | $-45M | $-56M | $-40M | $-47M | $-45M | · | $-46M | $-37M | $-38M | · | $-58M | |
| Stockholders' Equity | $1.18B | $1.20B | $1.27B | $1.31B | $1.30B | $1.31B | $1.37B | $1.40B | $1.40B | $1.25B | $1.39B | $1.44B | $1.54B | $1.55B | $1.56B | $1.63B | |
| Liabilities + Equity | $1.83B | $1.86B | $1.93B | $2.00B | $1.97B | $2.13B | $2.20B | $2.26B | $1.98B | $1.97B | · | $2.06B | $2.16B | $2.17B | · | $2.22B | |
| Shares Outstanding | · | · | · | · | · | · | · | 712,283,206 | 727,176,232 | 726,791,854 | · | 781,711,885 | 781,693,135 | 781,306,164 | 781,306,164 | 781,341,231 |
现金流 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $26M | $26M | $26M | $26M | $26M | $25M | $28M | |
| Stock-based Comp | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Deferred Tax | $-6M | $-8M | $-10M | $18M | $-16M | $-7M | $7M | $12M | $-2M | $-3M | $-7M | $6M | $2M | $102.0K | $-26M | $-40M | |
| Amort. of Intangibles | $19M | $19M | $19M | $20M | $19M | $20M | $20M | $20M | $20M | $21M | $21M | $22M | $22M | $21M | $22M | $21M | |
| Other Non-cash | · | $18M | · | · | · | $14M | · | · | · | $21M | · | · | · | $-34M | · | · | |
| Operating Cash Flow | $-44M | $-19M | $-26M | $-35M | $-83M | $-35M | $-44M | $-77M | $-26M | $-36M | $-38M | $33M | $-365.0K | $-23M | $-32M | $-32M | |
| CapEx | $3M | $2M | $3M | $3M | $3M | $3M | $5M | $8M | $7M | $4M | $3M | $4M | $6M | $3M | $6M | $8M | |
| Investing Cash Flow | $16M | $-2M | $-2M | $195M | $-3M | $41M | $116M | $248M | $-7M | $-4M | $-1M | $-4M | $-5M | $-8M | $-8M | $-5M | |
| Stock Repurchased | $13M | $5M | $14M | $15M | $18M | $0 | $16M | $24M | $0 | $50M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-5M | · | · | · | $0 | · | · | · | $-50M | · | · | · | · | · | · | |
| Financing Cash Flow | $-13M | $-5M | $-18M | $-16M | $-79M | $-4M | $-40M | $206M | $-2M | $21M | $-4M | $2M | $3M | $-13M | $10M | $8M | |
| Net Change in Cash | $-41M | $-27M | $-46M | $143M | $-164M | $4M | $26M | $379M | $-35M | $-20M | $-43M | $31M | $-3M | $-42M | $-28M | $-30M | |
| Taxes Paid | $35.0K | $-3M | $4M | $763.0K | $18M | $2M | $6M | $2M | $513.0K | $1M | $5M | $-2M | $208.0K | $477.0K | $4M | $-176.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-38M | · | · | · | $-40M | · | · | · | $-26M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-48M | · | · | · | · | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.9% | 36.8% | · | 32.9% | 31.5% | 28.4% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -4.3% | -41.1% | · | 31.7% | -38.2% | -44.8% | · | 8.2% | -33.9% | -41.1% | · | -36.1% | 2.6% | -12.9% | · | -48.9% | |
| Net Margin | -5.1% | -44.2% | · | 14.3% | -94.7% | -45.1% | · | 14.3% | -5.7% | -47.1% | · | -47.3% | -7.4% | -7.7% | · | -47.9% | |
| Pretax Margin | -8.2% | -49.1% | · | 27.3% | -103.6% | -48.9% | · | 27.9% | -5.8% | -47.9% | · | -43.9% | -6.2% | -7.1% | · | -70.3% | |
| EBITDA Margin | 9.4% | -23.2% | · | 46.7% | -23.6% | -29.1% | · | 22.1% | -20.6% | -26.3% | · | -21.4% | 12.6% | -1.8% | · | -33.3% | |
| ROA | -0.44% | -2.8% | · | 1.0% | -7.5% | -3.3% | · | 1.1% | -0.50% | -4.0% | · | -4.0% | -0.87% | -0.82% | · | -3.7% | |
| ROE | -0.68% | -4.4% | · | 1.6% | -11.0% | -5.3% | · | 1.8% | -0.70% | -5.8% | · | -5.5% | -1.2% | -1.1% | · | -5.1% | |
| ROIC | -0.37% | -3.8% | · | 1.9% | -4.2% | -4.7% | · | 0.52% | -4.3% | -5.6% | · | -4.8% | 0.54% | -2.1% | · | -3.7% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.6 | · | 3.7 | 3.4 | 2.5 | · | 3.0 | 1.6 | 1.9 | · | 1.8 | 1.9 | 1.8 | · | 1.5 | |
| Quick Ratio | 2.6 | 2.8 | · | 3.0 | 2.1 | 1.8 | · | 2.4 | 0.7 | 0.9 | · | 1.3 | 1.4 | 1.0 | · | 1.1 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.3 | · | -19.0 | 2.1 | · | · | · |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.3 | 1.2 | · | 1.6 | 1.7 | 1.7 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.8 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.6 | 1.2 | 1.5 | · | 1.5 | 1.4 | 1.4 | · | 1.0 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $588M | $581M | · | $642M | $664M | $689M | · | $711M | $716M | $800M | · | $867M | $868M | $913M | · | $1.22B | |
| Net Income TTM | $-73M | $-213M | · | $-180M | $-177M | $-39M | · | $-134M | $-243M | $-252M | · | $-208M | $-209M | $-291M | · | $-317M | |
| Market Cap | · | · | · | · | · | · | · | $1.06B | $909M | $872M | · | $1.25B | $1.70B | $1.14B | · | $1.48B | |
| Enterprise Value | · | · | · | · | · | · | · | $666M | $874M | $802M | · | $1.12B | $1.60B | · | · | · | |
| P/E | -16.7 | -4.2 | · | -6.2 | -5.3 | -23.7 | · | -7.1 | · | · | · | -4.6 | -5.7 | -3.8 | · | -4.3 | |
| P/S | · | · | · | · | · | · | · | 1.5 | 1.3 | 1.1 | · | 1.4 | 2.0 | 1.2 | · | 1.2 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 0.7 | 0.7 | · | 0.9 | 1.1 | 0.7 | · | 0.9 | |
| P / Tangible Book | · | · | · | · | · | · | · | 4.7 | 4.4 | 20.7 | · | 13.6 | 10.9 | 7.6 | · | 6.7 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -24.5 | · | · | · | -50.4 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -21.8 | · | · | · | -44.4 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | 17.4 | -23.3 | -17.6 | · | -29.3 | 47.9 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -20.1 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 0.9 | 1.2 | 1.0 | · | 1.3 | 1.8 | · | · | · | |
| Earnings Yield | -6.0% | -23.7% | · | -16.1% | -18.9% | -4.2% | · | -14.1% | · | · | · | -21.9% | -17.5% | -26.0% | · | -23.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $607M | $713M | $863M | $1.00B | $1.77B |
| 毛利率 % | 33.9% | — | — | — | — |
| 营业利润率 % | -19.4% | — | -18.2% | -22.5% | — |
| 净收入 | $-226M | $-53M | $-189M | $-328M | $-30M |
| 稀释后每股收益 (EPS) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.3 | — | 0.0 | — | — |
| 流动比率 | 4.0 | — | 1.5 | 1.8 | — |
| 速动比率 | 3.1 | — | 1.1 | 1.3 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-191M | — | $-44M | $-120M | — |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 249 家申报者 · $248.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 31 (-8 与上一季度对比) | 30 (+6 与上一季度对比) | 70 (+20 与上一季度对比) | 50 (-14 与上一季度对比) | +35.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 36 位内幕人士 · 11 位高管 · 23 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Phillip Frost, M.D. | CEO & Chairman | 2025年5月27日 A | 3568951 | 0 | 0 | $0 |
| Adam Logal | Sr. Vice President, CFO | 2026年7月24日 F | 563396 | 0 | 0 | $0 |
| Juan F Rodriguez | Sr. Vice President, CFO | 2012年7月16日 A | — | 0 | 0 | $0 |
| Elias A. Zerhouni | Vice Chairman and President | 2025年5月27日 A | 589600 | 0 | 0 | $0 |
| Dale R Pfost | President | 2007年3月29日 J | 1687261 | 0 | 0 | $0 |
| Steven D Rubin | Executive VP-Administration | 2026年7月24日 F | 6571966 | 0 | 0 | $0 |
| Gary J. Nabel | Chief Innovation Officer | 2025年5月27日 A | 700579 | 0 | 0 | $0 |
| HSIAO JANE PH D | Vice Chairman & CTO | 2025年5月27日 A | 28499880 | 0 | 0 | $0 |
| Jon R Cohen | SVP OPKO; Exec Chairman BRLI | 2021年5月10日 P | 125000 | 0 | 0 | $0 |
| Naveed K Shams | Chief Medical Officer & Sr. VP of Research & Development | 2008年7月7日 P | 6200 | 0 | 0 | $0 |
| Samuel J Reich | Executive VP | 2007年3月29日 J | 490021 | 0 | 0 | $0 |
| Prem A Lachman | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| Alice Lin-Tsing Yu | 董事 | 2026年6月18日 A | 100000 | 0 | 0 | $0 |
| Subbarao V Uppaluri | 董事 | 2026年6月18日 A | 162000 | 0 | 0 | $0 |
| John A Paganelli | 董事 | 2026年6月18日 A | 394340 | 1 | 0 | $11400 |
| Richard C Pfenniger JR | 董事 | 2026年6月18日 A | 325000 | 0 | 0 | $0 |
| Roger Medel MD | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| Richard M Krasno | 董事 | 2025年4月23日 A | 103333 | 0 | 0 | $0 |
| Alexis Borisy | 董事 | 2023年6月22日 A | 312612 | 0 | 0 | $0 |
| Anthony J Japour | 董事 | 2020年3月12日 P | 1000 | 0 | 0 | $0 |
| Robert A Baron | 董事 | 2017年1月19日 M | 320773 | 0 | 0 | $0 |
| Dmitry Kolosov | 董事 | 2016年5月5日 A | — | 0 | 0 | $0 |
| Pascal J Goldschmidt | 董事 | 2011年6月9日 A | — | 0 | 0 | $0 |
| Michael Reich | 董事 | 2009年1月6日 M | 202858 | 0 | 0 | $0 |
| David A Eichler | 董事 | 2007年9月19日 A | — | 0 | 0 | $0 |
| Melvin L Rubin MD | 董事 | 2007年5月3日 A | — | 0 | 0 | $0 |
| SPENCER DAVID LEE | 董事 | 2006年7月3日 A | 809100 | 0 | 0 | $0 |
| Robert S Benou | 董事 | 2006年7月3日 A | 35000 | 0 | 0 | $0 |
| Opko Health, Inc. | 10% 所有者 | 2024年8月19日 S | 2646972 | 0 | 0 | $0 |
| Frost Gamma Investments Trust | 10% 所有者 | 2007年7月13日 P | 40589183 | 0 | 0 | $0 |
| Frost Group, LLC | 10% 所有者 | 2007年3月27日 A | — | 0 | 0 | $0 |
| Robert Scott Fishel | — | 2021年6月24日 A | 60000 | 0 | 0 | $0 |
| Richard A Lerner | — | 2021年6月24日 A | 178881 | 0 | 0 | $0 |
| Thomas E Beier | — | 2017年1月13日 M | 60000 | 0 | 0 | $0 |
| John J Huntz JR | — | 2004年5月27日 A | 35000 | 0 | 0 | $0 |
| Gordon F Martin | — | 2003年11月10日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 21 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL, Frost Gamma Investments Trust, Frost Nevada Investments Trust ×3 申报 | 2026年7月1日 | 34.10% | 修订 | — | SEC |
| HSIAO JANE PH D, Hsu Gamma Investments, LP | 2025年4月3日 | 4.50% | 修订 | — | SEC |
| OPKO Health, Inc. ×30 申报 | 2024年11月20日 | — | 初始申报 | — | SEC |
| Frost Gamma Investments Trust, Frost Nevada Investments Trust, Phillip Frost, M.D. ×6 申报 | 2024年11月15日 | — | 初始申报 | — | SEC |
| Hsu Gamma Investments, LP, Jane H. Hsiao, Ph.D. ×2 申报 | 2024年1月24日 | — | 初始申报 | — | SEC |
| Gary J. Nabel, M.D., Ph.D., Elizabeth G. Nabel, M.D., Coe M. Magruder, EGN 2021 Trust, GJN 2021 Trust, Nabel Family Investments LLC | 2022年6月29日 | — | 初始申报 | 被动投资 | SEC |
| Elias A. Zerhouni, M.D., Bruce C. Holbrook, EAZ Zeraz Trust, Zerhouni Irrevocable Trust | 2022年6月29日 | — | 初始申报 | — | SEC |
| Hsu Gamma Investment, L.P., Jane Hsiao, Ph.D. | 2020年3月20日 | — | 初始申报 | — | SEC |
| The Chiin Hsiung Hsiao Family Trust A, The Chiin Hsiung Hsiao Family Trust B, Hsu Gamma Investment, L.P., Jane Hsiao, Ph.D. | 2019年11月1日 | — | 初始申报 | 被动投资 | SEC |
| The Frost Group, LLC, Frost Gamma Investments Trust, Frost Nevada Investments Trust, Phillip Frost, M.D. ×15 申报 | 2019年11月1日 | — | 初始申报 | 被动投资 | SEC |
| The Chiin Hsiung Hsiao Family Trust A (2), The Chiin Hsiung Hsiao Family Trust B (2), Hsu Gamma Investment, L.P. (2), Jane Hsiao, Ph.D. (2) | 2018年11月20日 | — | 初始申报 | — | SEC |
| Jane Hsiao, Ph.D., The Chiin Hsiung Hsiao Family Trust A, The Chiin Hsiung Hsiao Family Trust B, Hsu Gamma Investment, L.P. ×4 申报 | 2015年12月18日 | — | 初始申报 | 被动投资 | SEC |
| The Frost Group, LLC (2), Frost Gamma Investments Trust (2), Phillip Frost, M.D. (2) ×4 申报 | 2015年2月17日 | — | 初始申报 | 被动投资 | SEC |
| OPKO Health, Inc. (2) ×2 申报 | 2014年1月7日 | — | 初始申报 | — | SEC |
| Jane Hsiao, Ph.D. (2), The Chiin Hsiung Hsiao Family Trust A (2), The Chiin Hsiung Hsiao Family Trust B (2), Hsu Gamma Investment, L.P. (2) | 2013年9月16日 | — | 初始申报 | 并购/出售 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 35 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.46% | 76590 SH | 2026年8月8日 | 每日 |
| IHF · iShares Trust | 0.09% | 816616 SH | 2026年8月8日 | 每日 |
| SMMV · iShares Trust | 0.08% | 165752 SH | 2026年8月8日 | 每日 |
| GSSC · Goldman Sachs ETF Trust | 0.05% | 327900 NS | 2026年5月31日 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 351316 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.04% | 2750548 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.03% | 3790040 SH | 2026年8月8日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.02% | 139884 NS | 2026年4月30日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 2317304 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 395548 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.02% | 10264920 SH | 2026年8月8日 | 每日 |
| ISCV · iShares Trust | 0.02% | 86918 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.02% | 19367 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.01% | 178325 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 2044519 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 4912704 SH | 2026年8月8日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.01% | 6907600 SH | 2026年8月8日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.01% | 1985904 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 1144903 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.01% | 15146 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 200102 NS | 2026年4月30日 | N-PORT |
| ISCB · iShares Trust | 0.01% | 17135 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.01% | 15321 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 449453 NS | 2026年5月31日 | N-PORT |
| WSML · iShares Trust | 0.01% | 27130 SH | 2026年8月8日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 23187 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 58520 NS | 2026年4月30日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 385 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 330176 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 750774 SH | 2026年8月8日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 341321 NS | 2026年4月30日 | N-PORT |
| IWV · iShares Trust | 0.00% | 102451 SH | 2026年8月8日 | 每日 |
| VBR · VANGUARD INDEX FUNDS | 0.00% | 2195542 SH | 2026年8月8日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 9753393 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 32355 SH | 2026年8月8日 | 每日 |